mitoxantrone

Commonly Used FDA Approved Treatments for Metastatic Castrate Resistant Prostate Cancer (mCRPC)

The first line of treatment for advanced prostate cancer is Androgen (male hormone) Deprivation Therapy or ADT. Once the PSA progresses (climbs) while still on ADT and with testosterone levels

By |2017-10-19T10:49:31-04:00September 3rd, 2013|abiraterone acetate, Advanced Prostate Cancer, Alpha Emitting Radio Therapy, Alpharadin (radium-223), Cabazitaxel, Chemo Therapy, Chemo Therapy Failure, Choline C11, Drugs & Treatments, Enzalutamide (MDV-3100), General Information, Hormone Therapy, MDV3100, Uncategorized, Understanding APC, Xofigo, Xtandi, Zytiga|2 Comments
Read More

A Clinical Trial : Ixabepilone, Mitoxantrone, and Prednisone in Treating Patients with Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy

I was recently reviewing current clinical trials and came across this one for men who have failed chemotherapy, what many of us view as the final treatment for advanced prostate cancer. It provides a potential opportunity to combine two different therapy agents (one old, mitoxantrone; one relatively new, ixabepilone). Both of these chemicals are known [...]

By |2020-02-04T10:11:12-05:00February 2nd, 2009|Advanced Prostate Cancer, Chemo Therapy, Chemo Therapy Failure, Clinical Trials, Clinical Trials, Uncategorized|7 Comments
Read More
Go to Top